Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2568577278;77279;77280 chr2:178569079;178569078;178569077chr2:179433806;179433805;179433804
N2AB2404472355;72356;72357 chr2:178569079;178569078;178569077chr2:179433806;179433805;179433804
N2A2311769574;69575;69576 chr2:178569079;178569078;178569077chr2:179433806;179433805;179433804
N2B1662050083;50084;50085 chr2:178569079;178569078;178569077chr2:179433806;179433805;179433804
Novex-11674550458;50459;50460 chr2:178569079;178569078;178569077chr2:179433806;179433805;179433804
Novex-21681250659;50660;50661 chr2:178569079;178569078;178569077chr2:179433806;179433805;179433804
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: L
  • RefSeq wild type transcript codon: CTT
  • RefSeq wild type template codon: GAA
  • Domain: Fn3-74
  • Domain position: 85
  • Structural Position: 119
  • Q(SASA): 0.5715
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
L/F rs1707149968 None 0.755 N 0.64 0.216 0.513958542087 gnomAD-3.1.2 6.58E-06 None None None None I None 0 0 0 0 0 None 0 0 0 0 4.79386E-04
L/F rs1707149968 None 0.755 N 0.64 0.216 0.513958542087 gnomAD-4.0.0 2.47948E-06 None None None None I None 2.67101E-05 0 None 0 0 None 0 0 0 0 3.20359E-05

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
L/A 0.2095 likely_benign 0.2676 benign -1.167 Destabilizing 0.594 D 0.593 neutral None None None None I
L/C 0.5084 ambiguous 0.5801 pathogenic -0.709 Destabilizing 0.987 D 0.707 prob.neutral None None None None I
L/D 0.5233 ambiguous 0.617 pathogenic -0.518 Destabilizing 0.837 D 0.661 neutral None None None None I
L/E 0.2394 likely_benign 0.3107 benign -0.585 Destabilizing 0.015 N 0.444 neutral None None None None I
L/F 0.1344 likely_benign 0.1633 benign -0.988 Destabilizing 0.755 D 0.64 neutral N 0.477935242 None None I
L/G 0.5192 ambiguous 0.61 pathogenic -1.397 Destabilizing 0.911 D 0.676 prob.neutral None None None None I
L/H 0.2397 likely_benign 0.2983 benign -0.611 Destabilizing 0.961 D 0.752 deleterious N 0.473833866 None None I
L/I 0.0833 likely_benign 0.0899 benign -0.656 Destabilizing 0.011 N 0.515 neutral N 0.510800681 None None I
L/K 0.2845 likely_benign 0.3522 ambiguous -0.646 Destabilizing 0.041 N 0.617 neutral None None None None I
L/M 0.1038 likely_benign 0.1155 benign -0.474 Destabilizing 0.551 D 0.641 neutral None None None None I
L/N 0.3011 likely_benign 0.362 ambiguous -0.39 Destabilizing 0.911 D 0.747 deleterious None None None None I
L/P 0.3217 likely_benign 0.3943 ambiguous -0.793 Destabilizing 0.94 D 0.748 deleterious N 0.442996821 None None I
L/Q 0.1343 likely_benign 0.1755 benign -0.648 Destabilizing 0.036 N 0.433 neutral None None None None I
L/R 0.2688 likely_benign 0.351 ambiguous -0.02 Destabilizing 0.607 D 0.725 prob.delet. N 0.49715938 None None I
L/S 0.2125 likely_benign 0.2765 benign -0.934 Destabilizing 0.594 D 0.627 neutral None None None None I
L/T 0.2034 likely_benign 0.2514 benign -0.892 Destabilizing 0.468 N 0.616 neutral None None None None I
L/V 0.0842 likely_benign 0.0958 benign -0.793 Destabilizing None N 0.291 neutral N 0.448424071 None None I
L/W 0.3385 likely_benign 0.4016 ambiguous -0.977 Destabilizing 0.997 D 0.776 deleterious None None None None I
L/Y 0.3284 likely_benign 0.3895 ambiguous -0.751 Destabilizing 0.493 N 0.713 prob.delet. None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.